Hims & Hers investors may seek lead role in securities fraud case

By Atlas Watchline Staff · Legal · September 4, 2026

A law firm says Hims & Hers Health investors who lost money may seek to lead an ongoing securities fraud class action tied to alleged misleading statements.

The Law Offices of Frank R. Cruz said in a Sept. 4, 2026, press release that investors who lost money in Hims & Hers Health, Inc. may move to lead an ongoing securities fraud lawsuit. The notice names Nov. 2, 2026, as the lead plaintiff deadline.

According to the release, the complaint covers statements and omissions made between Aug. 4, 2025, and July 29, 2026. The filing alleges that Hims & Hers made materially false or misleading statements, or left out material facts, about its business, operations and outlook.

The press release says the complaint alleges the company shared consumers' health information with third-party advertising platforms. It also says the company charged consumers for prescriptions almost immediately after intake forms while telling them they could consult a medical provider to find a treatment that was

This is the AMP version of the article. Read the full article on Atlas Watchline.